Cargando…
Galactose treatment of a PGM1 patient presenting with restrictive cardiomyopathy
We report a patient diagnosed with PGM1‐CDG at 11 years of age after two biallelic likely pathogenic variants in PGM1 were found on research genomic sequencing. To our knowledge, he is the first patient with PGM1‐CDG to be reported with a restrictive cardiomyopathy. Other clinical manifestations inc...
Autores principales: | Donoghue, Sarah E., White, Susan M., Tan, Tiong Yang, Kowalski, Remi, Morava, Eva, Yaplito‐Lee, Joy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802629/ https://www.ncbi.nlm.nih.gov/pubmed/33473337 http://dx.doi.org/10.1002/jmd2.12177 |
Ejemplares similares
-
ORAL D-GALACTOSE SUPPLEMENTATION IN PGM1-CDG
por: Wong, Sunnie Yan-Wai, et al.
Publicado: (2017) -
PGM2 overexpression improves anaerobic galactose fermentation in Saccharomyces cerevisiae
por: Garcia Sanchez, Rosa, et al.
Publicado: (2010) -
Successful heart transplantation in an infant with phosphoglucomutase 1 deficiency (PGM1‐CDG)
por: Altassan, Ruqaiah, et al.
Publicado: (2022) -
Novel insights into the phenotype and long-term D-gal treatment in
PGM1-CDG: a case series
por: Radenkovic, Silvia, et al.
Publicado: (2023) -
Atomic Regulation of PGM Electrocatalysts for the Oxygen Reduction Reaction
por: Wu, Menghao, et al.
Publicado: (2021)